Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Scholar rock holding - The Real Truth

Why Is Scholar Rock Stock Trading Lower On Monday?

Scholar Rock Holding Inc. (NASDAQ:SRRK) stock is falling on Monday with a session volume of 8.19 million versus the average volume of 2.08 million, as per data from Benzinga Pro.

Benzinga · Oct 13, 2025

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Benzinga · Oct 28, 2022

Where Scholar Rock Holding Stands With Analysts

Scholar Rock Holding (NASDAQ:SRRK) has observed the following analyst ratings within the last quarter:

Benzinga · Jun 23, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Scholar Rock Holding Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q1, Scholar Rock Holding (NASDAQ:SRRK) posted sales of $33.19 million. Earnings were up 77.86%, but Scholar Rock Holding still reported an overall loss of $7.95 million.

Benzinga · Jun 22, 2022

What 4 Analyst Ratings Have To Say About Scholar Rock Holding

Over the past 3 months, 4 analysts have published their opinion on Scholar Rock Holding (NASDAQ:SRRK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · May 24, 2022

Recap: Scholar Rock Holding Q1 Earnings

Scholar Rock Holding (NASDAQ:SRRK) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Benzinga · May 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022

Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and a 52-week-low of $7.66. E2open Parent Holdings closed at $9.37 at the end of the last trading period.

Benzinga · Mar 23, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Benzinga

Organisations

Rigel Pharmaceuticals

15 stories

American Woodmark

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.